Loading company…
Upstream Medical Technologies Ltd. develops Marker C, a blood test that helps triage chest pain patients for unstable angina.
Marker C is a patented blood test that detects unstable angina within hours of a patient arriving at an emergency room, and it is sold to emergency departments and cardiac clinics, sometimes on subscription. Founded in 2015 in Christchurch, New Zealand, the company is led by CEO Kieran Jina. It raised USD 2.00 mn in funding led by Pacific Channel on May 17, 2023, with participation from Angel Investors Marlborough, Booster Innovation Fund and K1W1.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in